IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
37 hedge funds and large institutions have $8.67M invested in ImmunoCellular Therapeutics, Ltd. in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 14 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
79% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 14
Holders
37
Holding in Top 10
–
Calls
$724K
Puts
$2.52M
Top Buyers
| 1 | +$781K | |
| 2 | +$318K | |
| 3 | +$280K | |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
+$92K |
| 5 |
IFS
Ifrah Financial Services
Little Rock,
Arkansas
|
+$73K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$644K | |
| 3 | -$427K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$422K |
| 5 |
D.E. Shaw & Co
New York
|
-$391K |